BGCS Podcast

BGCS
  • 0.0 (0)
  • MEDICINE

The BGCS Podcast Series aims to provide high-quality, accessible, and free educational content for all those working in or interested in gynaecological oncology. Through regular episodes, the series will explore key topics across the specialty, including clinical care, surgical and systemic innovation, survivorship, and the management of inherited cancer risk. Each episode brings together expert clinicians, researchers, and people with lived experience to discuss emerging evidence, evolving guidance, and real-world challenges in practice. The focus is on translating research and policy into meaningful improvements in patient care, while supporting multidisciplinary learning and professional development. By offering open access to these conversations, BGCS seeks to foster shared understanding, critical discussion, and continued excellence across the gynaecological oncology community.

Episodes

  1. JAN 5

    Menopause care after cancer and in those at hight risk of cancer

    In this episode of the BGCS podcast, I am joined by Dr Kristyn Manley from the University Hospitals Bristol Menopause Service, and Georgina Hoffmann, who lives with Lynch syndrome. Together, we focus on the challenges and consequences of surgical menopause for women who have had gynaecological cancer or who undergo risk-reducing surgery because of an inherited cancer predisposition. The conversation explores the profound physical and psychological impact of abrupt menopause following bilateral oophorectomy, often at a young age. We discuss how surgical menopause differs from natural menopause, with more sudden and severe symptoms including vasomotor symptoms, sexual dysfunction, sleep disturbance, cognitive change, and long-term risks to bone and cardiovascular health. Dr Manley provides expert insight into the management of surgical menopause in women with cancer or increased cancer risk, addressing common misconceptions around hormone replacement therapy. She outlines when HRT can be safely offered, how decisions should be individualised based on cancer type and risk profile, and the importance of not denying symptom relief by default. Non-hormonal strategies and supportive interventions are also discussed, particularly for women in whom HRT is contraindicated or declined. Georgina Hoffmann shares her lived experience of surgical menopause in the context of Lynch syndrome, highlighting the real-world impact of risk-reducing surgery on quality of life, identity, and wellbeing. Her contribution reinforces the importance of early counselling, realistic expectations, and ongoing specialist follow-up rather than viewing surgery as the end of the care pathway. The episode emphasises the need for closer integration between gynaecological oncology, genetics, and menopause services, and calls for proactive, compassionate, and evidence-based care for women experiencing surgical menopause. It makes a strong case for recognising menopause management as a core component of cancer survivorship and inherited cancer risk care, rather than an optional add-on. Link to ERN https://www.genturis.eu/l=eng/home.html

    52 min

  2. 06/25/2025

    BGCS 2025 London

    Welcome to this special episode of the BGCS podcast, where we’re spotlighting one of the biggest events in the gynaecological cancer calendar – the British Gynaecological Cancer Society Annual Scientific Meeting 2025, taking place in just two weeks in the heart of London. We’re thrilled to be joined by two exceptional guests. First, Professor Ronny Drapkin, internationally renowned for his pioneering work identifying the fallopian tube as the origin of many high-grade serous ovarian cancers – a discovery that has fundamentally reshaped our understanding of this disease. And second, Professor Ranjit Manchanda, Chair of BGCS ASM 2025, who gives us a preview of what to expect at this year’s meeting – from cutting-edge science and surgical innovation, to global collaboration and the latest in prevention and early detection. Whether you're a clinician, researcher, nurse specialist or trainee, this episode will get you excited for the science, the networking, and the vision driving progress in gynaecological oncology. Let’s dive in.

    38 min

  3. 12/17/2024

    Cervical cancer screening - the challenges and novel remedies

    Today, in our episode before Christmas, I get the discuss the current challenges in cervical screening with Dr Tracie Miles (The Eve Appeal) and Dr Jen Davies (University of Manchester). We talk all manner of things, from barriers to uptake both in the UK and in resource poor settings to urine based/non-invasive screening methods. We also highlight the best ways to communicate to patients in colposcopy and the areas of communication we often get wrong. Enjoy

    49 min

  4. 10/08/2024

    The evidence and the experience of using HIPEC in ovarian cancer

    Today we talk to Prof Willemien van Driel and Ms Claire Thompson on the the topic of HIPEC in ovarian cancer. Prof Van Driel outlines the formidable evidence base she has done so much to create. In addition, Ms Claire Thompson describes her experience of setting up a service in the republic of Ireland.

    41 min

  5. 07/25/2024

    Professor Ranjit Manchanda - NICE guidelines and delayed RRS

    Professor Ranjit Manchanda discusses the new NICE guidance https://www.nice.org.uk/guidance/ng241 - what it means for our community. We also discuss his amazing career along side his current research which seeks to improve the diagnosis of high risk gremline pathogenic variants as well as the PROTECTOR study. https://www.qmul.ac.uk/fmd/research/protector/

    35 min

  6. 04/10/2024

    The SHAPE trial - a discussion with Dr Plante

    In this episode we discuss the practice changing SHAPE trial with lead author Dr Plante. https://www.nejm.org/doi/full/10.1056/NEJMoa2308900

    47 min

  7. 02/12/2024

    When to operate in ovarian cancer

    In our inaugural podcast, we hear from two international experts, Professor Christina Fotopoulou of Imperial College London and Professor Sean Kehoe of Oxford University, discussing the pros and cons of interval vs primary surgery for the management of ovarian cancer. The debate covers the full gambit of the current and ongoing evidence base.

    53 min
  • 7 Episodes

About

The BGCS Podcast Series aims to provide high-quality, accessible, and free educational content for all those working in or interested in gynaecological oncology. Through regular episodes, the series will explore key topics across the specialty, including clinical care, surgical and systemic innovation, survivorship, and the management of inherited cancer risk. Each episode brings together expert clinicians, researchers, and people with lived experience to discuss emerging evidence, evolving guidance, and real-world challenges in practice. The focus is on translating research and policy into meaningful improvements in patient care, while supporting multidisciplinary learning and professional development. By offering open access to these conversations, BGCS seeks to foster shared understanding, critical discussion, and continued excellence across the gynaecological oncology community.

Information

  • Creator
    BGCS
  • Years Active
    2024 - 2026
  • Episodes
    7
  • Copyright
    © BGCS
  • Show Website
    BGCS Podcast